ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
7¿ù ÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ Å°¿öµå ¹× ³×Æ®¿öÅ© ºÐ¼®
±×¸² 1. ÀÇ°úÇÐ 7¿ù ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå
ÃֽŠÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå´Â Risk, Neoplasms, COVID-19, Women, Genes, General Surgery, Role, Attention, Drug, Humans, Economics, Mortality, Population, Survival Rate, Pain, Vaccination, Older Adults µîÀ¸·Î ³ªÅ¸³µ´Ù. ÀÇ°úÇÐºÐ¾ß ÃֽŠ¿¬±¸µ¿Çâ Å°¿öµå ¹× ³×Æ®¿öÅ© ºÐ¼®À» À§ÇÏ¿© ÀÓ»óÀÇÇÐ, ±âÃÊÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, Ä¡ÀÇÇÐ, ¹× °£È£ÇÐ ºÐ¾ß¸¦ ÅëÇÕÇÏ¿© Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 7¿ù¿¡ ¹ßÇ¥ÇÑ ³í¹®À» ºÐ¼®ÇÏ¿´´Ù.
Ç¥ 1. 7¿ù ÀÇ°úÇÐ ÅëÇÕ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(N=3,660)
Å°¿öµå ¼øÀ§
|
±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
1
|
COVID-19
|
Risk
|
Risk
|
2
|
Risk
|
Neoplasms
|
Neoplasms
|
3
|
Women
|
Genes
|
COVID-19
|
4
|
Neoplasms
|
Women
|
Women
|
5
|
Genes
|
General Surgery
|
Genes
|
6
|
General Surgery
|
Attention
|
General Surgery
|
7
|
Education
|
COVID-19
|
Role
|
8
|
Role
|
Role
|
Attention
|
9
|
Pain
|
Humans
|
Drug
|
10
|
Vaccination
|
Economics
|
Humans
|
±×¸² 2. ±¹³» ¹ßÇ¥ 7¿ù ÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼®
±×¸² 3. ±¹¿Ü ¹ßÇ¥ 7¿ù ÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
Ç¥ 2. ÀÇ°úÇÐ 7¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ
Topic1
|
Topic2
|
Topic3
|
Topic4
|
Topic5
|
Tooth
|
COVID-19
|
Neoplasms
|
Role
|
COVID-19
|
Syndrome
|
Education
|
General Surgery
|
Neoplasms
|
Attention
|
Complication
|
Risk
|
F-18 Fdg Pet
|
Genes
|
Water
|
Death
|
Women
|
Sensitivity And Specificity
|
Humans
|
Drug
|
Risk
|
Behavior
|
Pain
|
Economics
|
Vaccination
|
Mortality
|
Bmi
|
Survival Rate
|
Inflammation
|
Economics
|
General Surgery
|
Older Adults
|
Risk
|
Brain
|
Technology
|
Stroke
|
Depression
|
Women
|
Liver
|
Environment
|
Bone And Bones
|
Adult
|
Breast Neoplasms
|
Serum
|
Efficiency
|
Women
|
Pediatrics
|
Recurrence
|
Apoptosis
|
Anti-Bacterial Agents
|
±×¸² 4. 7¿ù ÀÇ°úÇÐºÐ¾ß ÅëÇÕ Å°¿öµå ÃßÃ⠸𵨸µ ³×Æ®¿öÅ© ºÐ¼®
ÀÇ°úÇÐ ¿¬±¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹® µ¥ÀÌÅÍ´Â 7¿ù¿¡ ±¹³» Àú³Î°ú ±¹¿Ü Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹® Áß¿¡¼ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)ÀÇ Æà¸Þµå(PubMed) MEDLINE µ¥ÀÌÅͺ£À̽º¿¡¼ ³í¹®ÀڷḦ ÃßÃâÇÏ¿© ºÐ¼®ÇÏ¿´´Ù. ±¹³»¿Í ±¹¿Ü Àú³ÎÀ» ÅëÇÏ¿© ÀÇ°úÇÐ ºÐ¾ß¿¡ ¹ßÇ¥µÈ ³í¹® °Ç¼ö´Â ÃÑ 3,660ÆíÀ¸·Î Àü¿ù¿¡ ºñÇÏ¿© 444ÆíÀÌ Áõ°¡ÇÏ¿´´Ù. ÀÌ´Â ±¹³» Àú³ÎÀ» ÅëÇÑ ¹ßÇ¥°¡ 1,575ÆíÀ¸·Î ³ªÅ¸³µ°í ±¹¿Ü Àú³ÎÀ» ÅëÇÏ¿© 2,085ÆíÀ¸·Î ±¹³» Àú³Îº¸´Ù ±¹¿Ü Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹®ÀÌ Áö¼ÓÀûÀ¸·Î ³ô°Ô ³ªÅ¸³µ´Ù. ÀÇ°úÇÐ ºÐ¾ßº° ¹ßÇ¥ÇöȲÀ» »ìÆ캸¸é ÀÓ»óÀÇÇÐ 1,839Æí, ±âÃÊÀÇÇÐ 1,219Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 365Æí, Ä¡ÀÇÇÐ 134Æí, °£È£ÇÐ 104Æí ¼øÀ¸·Î ³ªÅ¸³µ´Ù.
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø
* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼ ¼ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.